Virttu Biologics ^Companies

Virttu Biologics is a pioneering biotechnology company that focuses on the development of oncolytic viruses for the treatment of cancer. As a privately held organization, Virttu has made significant advancements in the field of biotechnology and has become a leader in the development of innovative therapies for cancer patients. Their main goal is to improve the quality of mobile apps by working with the industry and providing resources to assist in app testing. With a focus on app quality, AQuA aims to contribute to the control and prevention of the spread of diseases such as Covid-19. In 2019, AQuA transitioned to a voluntary run basis, maintaining their knowledge base and continuing to provide valuable resources to the industry.